RHOEN-KLINIK.UNSP.ADR 1/2 Market Cap ($803.26 Million)
Market Cap & Net Worth: RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU)
RHOEN-KLINIK.UNSP.ADR 1/2 market cap. RHOEN-KLINIK.UNSP.ADR 1/2 (F:RHKU) has a market capitalization of $803.26 Million (€687.07 Million) as of October 31, 2026. Listed on the F stock exchange, this Germany-based company holds position #9603 globally and #1202 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RHOEN-KLINIK.UNSP.ADR 1/2's stock price €5.80 by its total outstanding shares 133876940 (133.88 Million).
RHOEN-KLINIK.UNSP.ADR 1/2 Market Cap History (2020–2026)
RHOEN-KLINIK.UNSP.ADR 1/2 market cap history from 2020 to 2026. Data shows change from $1.21 Billion to $1.07 Billion (-5.85% CAGR). Check RHOEN-KLINIK.UNSP.ADR 1/2 stock price for real-time trading data and today's change.
RHOEN-KLINIK.UNSP.ADR 1/2 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RHOEN-KLINIK.UNSP.ADR 1/2's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see RHKU cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.65x
RHOEN-KLINIK.UNSP.ADR 1/2's market cap is 0.65 times its annual revenue
Latest Price to Earnings (P/E) Ratio
23.83x
RHOEN-KLINIK.UNSP.ADR 1/2's market cap is 23.83 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.07 Billion | $1.40 Billion | $28.30 Million | 0.77x | 37.93x |
| 2022 | $1.12 Billion | $1.45 Billion | $25.14 Million | 0.77x | 44.53x |
| 2023 | $754.41 Million | $1.46 Billion | $38.71 Million | 0.52x | 19.49x |
| 2024 | $1.03 Billion | $1.60 Billion | $43.35 Million | 0.65x | 23.83x |
Competitor Companies of RHKU by Market Capitalization
Companies near RHOEN-KLINIK.UNSP.ADR 1/2 in the global market cap rankings as of October 31, 2026. See RHOEN-KLINIK.UNSP.ADR 1/2 balance sheet independence to understand what proportion of total assets are financed by equity.
Key companies related to RHOEN-KLINIK.UNSP.ADR 1/2 by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #290 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #907 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #993 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1215 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #290 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $478.08 |
| #907 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.00 |
| #993 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1215 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $270.57 |
Market Capitalization of RHOEN-KLINIK.UNSP.ADR 1/2 (2020–2026)
Market capitalization of RHOEN-KLINIK.UNSP.ADR 1/2 from 2020 to today. Between 2020 and today, RHOEN-KLINIK.UNSP.ADR 1/2's market cap moved from $1.21 Billion to $ 1.07 Billion, with a yearly change of -5.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.07 Billion | +12.30% |
| 2025 | €954.75 Million | -7.58% |
| 2024 | €1.03 Billion | +36.93% |
| 2023 | €754.41 Million | -32.62% |
| 2022 | €1.12 Billion | +4.32% |
| 2021 | €1.07 Billion | -11.60% |
| 2020 | €1.21 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of RHOEN-KLINIK.UNSP.ADR 1/2 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $803.26 Million USD |
| MoneyControl | $803.26 Million USD |
| MarketWatch | $803.26 Million USD |
| marketcap.company | $803.26 Million USD |
| Reuters | $803.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About RHOEN-KLINIK.UNSP.ADR 1/2
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company also operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.